Spotlight
Video

Outcomes from RESONATE Trial in Relapsed CLL

obr has 860 videos Subscribe Here

Loading........
Description: Paul M.Barr MD Associate Professor of Medicine at Wilmot Cancer Institute explains the results found of the RESONATE Trial that was evaluating ibrutinib versus ofatumumab in relapsed chronic lymphocytic leukemia (CLL).
Shared By : obr
Posted on : 06/25/19
Added : 2 months ago